超上腺体正静性低血压的长期结果
Robert Alexander Castro1, Patricio Millar Vernetti2, Italo Biaggioni1
1Vanderbilt University Medical Center.
Research square
|October 4, 2023
概括
超上腺体正静性低血压患者在七年内面临更高的死亡率和变现率. 这种亚型需要仔细监测不良结果.
科学领域:
- 心血管医学 心血管医学
- 神经学 神经学
- 自主神经科学 自主神经科学
背景情况:
- 超上腺体正静性低血压 (HOH) 是正静性低血压 (OH) 的一个亚型,在站立时会出现上腺素水平升高.
- 以前的研究表明,HOH与其他OH亚型相比,对自主功能障碍的严重性较小.
- 对HOH的长期结果仍未确定.
研究的目的:
- 评估HOH患者的7年全因死亡率和变现率.
- 为了比较HOH与其他形式的OH之间的结果.
主要方法:
- 对92名OH患者进行前性观察性研究.
- 基于垂直的北上腺素水平,分类为高上腺素 (n=34) 和非高上腺素 (n=58) 队列.
- 7年的随访评估死亡率和转化为神经退行性自主性疾病的现象.
主要成果:
- 在站立时,HOH患者表现出过度增加的北上腺素 (938 ± 305 pg/mL).
- 七年死亡率在HOH队列 (35%) 与OH队列 (22%,p=0.01) 相比,在HOH队列中明显高.
- OH H显示出更大的转化为多重系统缩 (p=0.04),而OH队列更容易转化为帕金森病和勒维体痴呆症.
结论:
- 尽管最初的自主功能障碍较小,但HOH与更糟糕的临床结果有关,包括更高的死亡率.
- 由于潜在的负面长期后果,HOH患者需要进行警监测.
- 研究结果表明,HOH可能与其他OH亚型不同地进展,可能导致特定的神经退行性疾病.
更多相关视频
06:51Development of an Algorithm to Perform a Comprehensive Study of Autonomic Dysreflexia in Animals with High Spinal Cord Injury Using a Telemetry Device
Published on: July 29, 2016
8.0K
14:28Software for Analysis of Heart Rate and Blood Pressure Time-series Data from the Valsalva Maneuver
Published on: June 27, 2025
154
相关概念视频
Heart Failure II: Pathophysiology
14
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
14
Alterations in Blood Pressure
1.3K
Alterations in blood pressure, such as hypertension (high blood pressure) and hypotension (low blood pressure), significantly affect human health. Understanding these conditions' classifications, causes, and symptoms is essential for effective management and treatment.
Hypertension (High blood pressure)
Hypertension occurs when blood pressure readings consistently exceed the normal range. It is diagnosed when systolic blood pressure (the top number, indicating pressure while the heart...
Hypertension (High blood pressure)
Hypertension occurs when blood pressure readings consistently exceed the normal range. It is diagnosed when systolic blood pressure (the top number, indicating pressure while the heart...
1.3K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
454
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
454
Disorders of the Autonomic Nervous System
687
The autonomic nervous system (ANS) is an intricate network of nerves that controls functions such as the regulation of heart rate, digestion, and blood pressure regulation. When this system malfunctions, it can lead to various disorders that affect multiple bodily functions. One common feature of many autonomic disorders is the involvement of smooth blood vessels, which play a crucial role in regulating blood flow throughout the body.
Raynaud's disease, also known as Raynaud's...
Raynaud's disease, also known as Raynaud's...
687
Heart Failure Drugs: β-Blockers
357
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
357
Heart Failure V: Medical Management
12
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
12
